PUBLIC REPORTING INFORMATION

Capital Health’s Accountable Care Organization (ACO) provides the following information in accordance with Medicare Shared Savings Program (MSSP) regulations at 42 CFR §425.308.

ACO Name and Location
Name: Capital Health Accountable Care Organization, LLC 
Location:
Capital Health
Attn: Department of Clinical Integration
750 Brunswick Avenue
Trenton, NJ 08638
E-mail: accountablecare@capitalhealth.org

Hours: Monday - Friday, 9 a.m. - 5 p.m.

ACO Primary Contact
Name: Elizabeth G. Mil, RN, BSN, MA
E-mail: bmil@capitalhealth.org  
Telephone: 609-394-6408
Fax: 609-394-4052

Organizational Information 
ACO Participants
ACO participants in joint ventures between ACO professionals and hospitals:

  • Jyoti K. Bhatia , MD
  • Joseph M. Dellacroce , MD 

ACO Governing Body 

Key Clinical and Administrative Leadership
ACO Executive/Medical Director: Robert J. Remstein, DO, MBA
Compliance Officer: Steve Miller, JD
ACO Organizational Chart

ACO Committees and Key Leadership Personnel

Governing Board:  Robert J. Remstein, DO, MBA, Chair 
Quality and Outcomes Committee:  Jessica Codjoe, MD, Chair 
Finance Committee:  Shane Fleming, MBA, Chair 
Participant Relations Committee:  Jerrold Gertzman, MD, Chair 

 

Identification of the Types of ACO Participants or Combinations of Participants that Formed the ACO
•Partnership or joint venture arrangement between hospitals employing ACO professionals
•Partnership between hospitals and ACO professionals
•A Federally Qualified Health Center (FQHC)

Amount of Shared Savings/Losses
• Agreement period beginning 2015, Performance Year(s) 2015: $0

Shared Savings Distribution
• Agreement period beginning 2015, Performance Year(s) 2015: $0

How Shared Savings Are Distributed
Reinvest in infrastructure    15% 
Distribution to ACO participants    85% 
Primary Care    75% 
Specialists    25% 

        

Public Reporting of SNF 3-Day Rule Waiver
Waiver Used Reporting Waiver Use 
No   No, our ACO does not use the SNF 3-Day Rule Waiver.

Quality Performance Results 
    2015 Reporting Period 
Measure number   Measure Name ACO Performance Rate  Mean Performance Rate (SSP ACOs) 
ACO-1  CAHPS: Getting Timely Care, Appointments and Information   81.87 80.61 
ACO-2 CAHPS: How Well Your Providers Communicate   95.26  92.65 
ACO-3 CAHPS: Patients’ Rating of Provider  93.43  91.94 
ACO-4 CAHPS: Access to Specialists   84.76  83.61 
ACO-5 CAHPS: Health Promotion and Education   65.04  59.06 
ACO-6  CAHPS: Shared Decision Making   74.42  75.17 
ACO-7  CAHPS: Health Status/
Functional Status  
70.94 72.30 
ACO-34  CAHPS: Stewardship of Patient Resources* 23.16  26.87 
ACO-8 Risk Standardized, All Condition Readmissions 15.02 14.86 
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)*  18.52  18.07 
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 45.06  54.60 
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 76.24  76.96 
ACO-38    All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions   59.54   62.92 
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.18 1.11 
ACO-10  Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)   0.97 1.04 
ACO-11  Percent of PCPs who Successfully Meet Meaningful Use Requirements  86.27% 76.22% 
ACO-39   Documentation of Current Medications in the Medical Record* 95.82%   84.07% 
ACO-13  Falls: Screening for Future Fall Risk   91.80%  56.46% 
ACO-14  Preventive Care and Screening: Influenza Immunization 66.55% 62.03% 
ACO-15  Pneumonia Vaccination Status for Older Adults  76.08% 63.73% 
ACO-16  Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up  62.83% 71.15% 
ACO-17  Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.09% 90.16% 
ACO-18  Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 20.48% 45.25% 
ACO-19  Colorectal Cancer Screening   53.36%  60.06% 
ACO-20 Breast Cancer Screening   67.26% 65.67% 
ACO-21  Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented   80.63% 70.04% 
ACO-40  Depression Remission at Twelve Months*  N/A  N/A 
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control   13.90% 20.38% 
ACO-41    Diabetes: Eye Exam*  29.00%  41.05% 
ACO-28  Hypertension: Controlling High Blood Pressure 72.38% 69.62% 
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 89.24% 83.82% 
ACO-31  Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)  85.29% 87.22% 
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 76.74%  77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery, *= Measure required beginning Reporting Year 2015. N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

Back to top